Evidence map›Paper›PMID 21687637›Full record

ArticlePloS one2011

Role and mechanism of arsenic in regulating angiogenesis.

Ling-Zhi Liu, Yue Jiang, Richard L Carpenter, Yi Jing, Stephen C Peiper, Bing-Hua Jiang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Paradoxical effects of arsenic in the lungs.Environmental health and preventive medicine · 2021
    Review
  9. Inorganic arsenic induces sex-dependent pathological hypertrophy in the heart.American journal of physiology. Heart and circulatory physiology · 2021
    Article
  10. Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection.International journal of molecular sciences · 2019
    Review
  11. Review
  12. Review
  13. Article
  14. Endothelial cell calpain as a critical modulator of angiogenesis.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ling-Zhi LiuDepartment of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
Yue Jiang
Richard L Carpenter
Yi Jing
Stephen C Peiper
Bing-Hua Jiang
Thomas Jefferson University · US

Funding

PI3K Pathway in Prostate Tumorigenesis and AngiogenesisR01CA109460 · NCI · WEST VIRGINIA UNIVERSITY · PI JIANG, BINGHUA · 2006 to 2010
$1.2M
WC-Co nanoparticles in initiating angiogenesis by reactive oxygen speciesR01HL091456 · NHLBI · WEST VIRGINIA UNIVERSITY · PI JIANG, BINGHUA · 2009 to 2010
$832k
Analysis of arsenic in inducing ROS, signaling pathways, and lung carcinogenesisR21ES017237 · NIEHS · WEST VIRGINIA UNIVERSITY · PI JIANG, BINGHUA · 2009 to 2010
$415k
NCI NIH HHS R01 CA109460NCI NIH HHS R01CA109460NHLBI NIH HHS R01 HL091456NHLBI NIH HHS R01HL091456NIEHS NIH HHS R21 ES017237NIEHS NIH HHS R21ES017237
6 · The paper itself

Abstract

Arsenic is a wide spread carcinogen associated with several kinds of cancers including skin, lung, bladder, and liver cancers. Lung is one of the major targets of arsenic exposure. Angiogenesis is the pivotal process during carcinogenesis and chronic pulmonary diseases, but the role and mechanism of arsenic in regulating angiogenesis remain to be elucidated. In this study we show that short time exposure of arsenic induces angiogenesis in both human immortalized lung epithelial cells BEAS-2B and adenocarcinoma cells A549. To study the molecular mechanism of arsenic-inducing angiogenesis, we find that arsenic induces reactive oxygen species (ROS) generation, which activates AKT and ERK1/2 signaling pathways and increases the expression of hypoxia-inducible factor 1 (HIF-1) and vascular endothelial growth factor (VEGF). Inhibition of ROS production suppresses angiogenesis by decreasing AKT and ERK activation and HIF-1 expression. Inhibition of ROS, AKT and ERK1/2 signaling pathways is sufficient to attenuate arsenic-inducing angiogenesis. HIF-1 and VEGF are downstream effectors of AKT and ERK1/2 that are required for arsenic-inducing angiogenesis. These results shed light on the mechanism of arsenic in regulating angiogenesis, and are helpful to develop mechanism-based intervention to prevent arsenic-induced carcinogenesis and angiogenesis in the future.

Indexed as

ArsenicCell Line, TumorEnzyme ActivationEpithelial CellsGene Expression RegulationHumansHypoxia-Inducible Factor 1Lung NeoplasmsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Neovascularization, PathologicProto-Oncogene Proteins c-aktReactive Oxygen SpeciesSignal TransductionTime FactorsVascular Endothelial Growth Factor AArsenicHypoxia-Inducible Factor 1Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Proto-Oncogene Proteins c-aktReactive Oxygen SpeciesVascular Endothelial Growth Factor A

Identifiers

PMID21687637
PMCPMC3110823
OpenAlexW1972726130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.